Concepedia

Ahmet Imrali

AI

5

Publications

529

Citations

5

H-Index

2015

Active since

Affiliations

Queen Mary University of London(Current)

Barts Health NHS Trust

Royal London Hospital

Ahmet Imrali is an author at Queen Mary University of London specializing in tumor biology, medicine, and oncology.

ORCID

Top concepts

Publications per year

2015–2021

5

Publications

5

Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System

Lei Xu, Xueying Mao, Ahmet Imrali et al. · PLoS ONE · 2015 · 223 citations · Full text

, , +20

Phase I clinical trial repurposing all-trans retinoic acid as a stromal targeting agent for pancreatic cancer

Hemant M. Kocher, Bristi Basu, Fieke E. M. Froeling et al. · Nature Communications · 2020 · 191 citations · Full text

Circulating cancer stem cells: the importance to select.

Ming-Hsin Yang, Ahmet Imrali, Christopher Heeschen · PubMed · 2015 · 61 citations · Full text

Rapamycin inhibits prostate cancer cell growth through cyclin D1 and enhances the cytotoxic efficacy of cisplatin.

Ahmet Imrali, Xueying Mao, Marc Yeste‐Velasco et al. · PubMed · 2016 · 30 citations · Full text

, , +14

Pentraxin 3 is a stromally-derived biomarker for detection of pancreatic ductal adenocarcinoma

Michelle R. Goulart, Jennifer Watt, Imran Siddiqui et al. · npj Precision Oncology · 2021 · 24 citations · Full text

Rows per page

1–5 of 5